missing translation for 'onlineSavingsMsg'
Learn More

Ter-119 Magnetic Particles - DM Rat anti-Mouse, BD IMag-DM, Clone: TER-119, BD

Rat Monoclonal Antibody

Brand:  BD Biosciences 558536

Product Code. 15859468

  • 815.00 € / Each

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

The TER-119 antibody reacts with a 52kDa molecule associated with glycophorin A on cells of the erythroid lineage in embryonic yolk sac, fetal liver, newborn liver, adult bone marrow, adult peripheral blood, and adult lymphoid organs. The TER-119 antigen is expressed on erythroid cells from pro-erythroblast through mature erythrocyte stages, but not on cells with BFU-E or CFU-E activities. The TER-119 epitope is not detected on hematopoietic stem cells, lymphoid cells, myeloid cells, or erythroleukemia lines. The TER-119 mAb is a component of the “lineage cocktail” used in studies of hematopoietic progenitors to detect, or deplete cells committed to the hematopoietic lineages.

Cell Separation

TRUSTED_SUSTAINABILITY
Specifications

Specifications

Ter-119 Magnetic Particles - DM
Monoclonal
BD IMag-DM
Rat
Affinity Purified
RUO
Primary
Store undiluted at 4°C
Flow Cytometry
TER-119
Aqueous buffered solution containing BSA and ≤0.09% sodium azide.
Mouse Fetal Liver
5 mL
Immunology
Mouse
IgG2b κ
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.